Your browser doesn't support javascript.
loading
Molecular Changes in Immunological Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells in Lymphoid Neoplasia.
Petinati, Nataliya A; Sadovskaya, Aleksandra V; Sats, Natalia V; Kapranov, Nikolai M; Davydova, Yulia O; Fastova, Ekaterina A; Magomedova, Aminat U; Vasilyeva, Anastasia N; Aleshina, Olga A; Arapidi, Georgiy P; Shender, Viktoria O; Smirnov, Igor P; Pobeguts, Olga V; Lagarkova, Maria A; Drize, Nina I; Parovichnikova, Elena N.
Afiliação
  • Petinati NA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia. loel@mail.ru.
  • Sadovskaya AV; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Sats NV; Lomonosov Moscow State University, Moscow, 119991, Russia.
  • Kapranov NM; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Davydova YO; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Fastova EA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Magomedova AU; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Vasilyeva AN; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Aleshina OA; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Arapidi GP; National Medical Research Center for Hematology, Ministry of Health of the Russian Federation, Moscow, 125167, Russia.
  • Shender VO; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency, Moscow, 119435, Russia.
  • Smirnov IP; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
  • Pobeguts OV; Moscow Institute of Physics and Technology, Dolgoprudny, 141700, Russia.
  • Lagarkova MA; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency, Moscow, 119435, Russia.
  • Drize NI; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
  • Parovichnikova EN; Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency, Moscow, 119435, Russia.
Biochemistry (Mosc) ; 89(5): 883-903, 2024 May.
Article em En | MEDLINE | ID: mdl-38880649
ABSTRACT
Immune system and bone marrow stromal cells play an important role in maintaining normal hematopoiesis. Lymphoid neoplasia disturbs not only development of immune cells, but other immune response mechanisms as well. Multipotent mesenchymal stromal cells (MSCs) of the bone marrow are involved in immune response regulation through both intercellular interactions and secretion of various cytokines. In hematological malignancies, the bone marrow stromal microenvironment, including MSCs, is altered. Aim of this study was to describe the differences of MSCs' immunological function in the patients with acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). In ALL, malignant cells arise from the early precursor cells localized in bone marrow, while in DLBCL they arise from more differentiated B-cells. In this study, only the DLBCL patients without bone marrow involvement were included. Growth parameters, surface marker expression, genes of interest expression, and secretion pattern of bone marrow MSCs from the patients with ALL and DLBCL at the onset of the disease and in remission were studied. MSCs from the healthy donors of corresponding ages were used as controls. It has been shown that concentration of MSCs in the bone marrow of the patients with ALL is reduced at the onset of the disease and is restored upon reaching remission; in the patients with DLBCL this parameter does not change. Proliferative capacity of MSCs did not change in the patients with ALL; however, the cells of the DLBCL patients both at the onset and in remission proliferated significantly faster than those from the donors. Expression of the membrane surface markers and expression of the genes important for differentiation, immunological status maintenance, and cytokine secretion differed significantly in the MSCs of the patients from those of the healthy donors and depended on nosology of the disease. Secretomes of the MSCs varied greatly; a number of proteins associated with immune response regulation, differentiation, and maintenance of hematopoietic stem cells were depleted in the secretomes of the cells from the patients. Lymphoid neoplasia leads to dramatic changes in the functional immunological status of MSCs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2024 Tipo de documento: Article